Glucagon-Like Peptide 1 Receptor Agonists and Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients With Type 2 Diabetes.
Saved in:
| Title: | Glucagon-Like Peptide 1 Receptor Agonists and Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients With Type 2 Diabetes. |
|---|---|
| Authors: | Noh Y; College of Pharmacy, Chonnam National University, Gwangju, South Korea., Yin H; Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Canada., Ben Ghezala I; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada.; Department of Ophthalmology, Dijon University Hospital, Dijon, France.; Clinical Investigation Center 1432, Clinical Epidemiology/Clinical Trials Unit, INSERM, Dijon University Hospital, Dijon, France., Yu OHY; Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Canada.; Division of Endocrinology, Jewish General Hospital, Montreal, Canada., Suissa S; Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Canada.; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada., Azoulay L; Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Canada.; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada.; Gerald Bronfman Department of Oncology, McGill University, Montreal, Canada. |
| Source: | Diabetes care [Diabetes Care] 2026 May 01; Vol. 49 (5), pp. 763-771. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
